Hans- Georg Rammensee. Publications 2. 00. Identification of an immunogenic HLA- A*0. This is a list of words, terms, concepts and slogans of Nazi Germany used in the historiography covering the Nazi regime. Some words were coined by Adolf Hitler and. Of course the return of 'The Walking Dead' is on our radar this month. See which other movies and TV shows we're excited about in IMDb Picks. Sturm der Liebe liken. SoapSpoiler.de & die Sturm der Liebe-Vorschau gibt es jetzt auch auf Facebook! T- cell epitope of the transcription factor PAX2. Attig, S., J. Simultaneous infiltration of polyfunctional effector and suppressor T cells into renal cell carcinomas. Neurological symptoms in patients with biopsy proven celiac disease. Diekmann, J., E. Procesing of two latent membrane protein 1 MHC class I epitoeps requires tripeptidyl peptidase II involvement. Feyerabend, S., S. Novel multi- peptide vaccination in HLA- A2+ hormone sensitive patients with biochemical relapse of prostate cancer. The Prostate 6. 9: 9. Fissolo, N., S. Naturally presented peptides on major histocompatibility complex I and II molecules eluted from central nervous system of multiple sclerosis patients. Proteomics 8: 2. 09. Hennige, A. M., T. Insulin- mediated cortical activity in the slow frequency rang eis diminished in obese mice and promotes physical inactivity. Diabetologia 5. 2: 2. Kuttruff, S., S. NKp. CD8 T cells. ISO1 and IDO2 are expressed in human tumors: levo- but not dextro- 1- methyl tryptophan inhibits tryptophan catabolism. Inhibitors of indoleamine- 2,3- dioxygenase for cancer therapy: can we see the wood for the trees? Cancer 9: 4. 45- 4. Meyer, V. S., O. Identification of natural MHC class II presented phosphopeptides and tumor- derived MHC class I phospholigands. Otz, T., L. A bispecific single- chain antibody that mediates target cell- restricted, supra- agonistic CD2. Leukemia 2. 3: 7. Rammensee, H.- G., H. Cancer vaccines: Some basic considerations. In: Genomic and Personalized Medicine. Eds.: Willard, H. F. 5. 73- 5. 89. Stickel, J., A. O. HLA ligand profiles of primary renal cell carcinoma maintained in metastases. Autoimmune T cell responses to antigenic peptides presented by bronchoalveolar lavage cell HLA- DR molecules in sarcoidosis. Weide, B., S. Direct injection of protamine- protected m. RNA: Results of a phase 1/2 vaccination trial in metastatic melanoma patients. Feldhahn, M., P. Epi. Tool. Kit – a web server for computational immunomics. E- pub. Herrmann, T., L. Construction of optimized bispecific antibodies for selective activation of the death receptor CD9. Hillen, N., G. Essential differences in ligand presentation and T cell epitope recognition among HLA molecules of the HLA- B4. Kloss, M., P. Interaction of monocytes with NK cells upon Toll- like receptor- induced expression of the NKG2. D ligand MICA. Levo- but not dextro- 1- methyl tryptophan abrogates the IDO activity of human dendritic cells. Blood 1. 11: 2. 15. Meyer, V. S., W. Long- term immunity against actual poxviral HLA ligands as identified by differential stable isotope labeling. Rudolf, D., T. Jung, B. S: Kwon, H.- G. Potent costimulation of human CD8 T cells by anti- 4- 1. BB and anti- CD2. Schatz, M., B. Characterizing the N- terminal processing motif of MHC class I ligands. Tschiedel, S., C. Identification of NM2. H2 as a tumour- associated antigen in chronic myeloid leukaemia. Leukemia 2. 2: 1. Wahlstr. Identification of HLA- DR- bound peptides prsented by human bronchoalveolar large cells in sarcoidosis. Waldhauer, I., D. Tumor- associated MICA is shed by ADAM proteases. Weide, B., J.- P. Results of the first phase I/II clinical vaccination trial with direct injection of m. RNA. 3. 1: 1. 80- 1. Weide, B., C. Plasmid DNA and messenger RNA- based anti- cancer vaccination. Weinzierl, A. O., D. Maurer, F: Altenberend, N. Schneiderhan- Marra, K. A cryptic vascular endothelial growth factor T- cell epitope: Identification and characterization by mass spectrometry and T- cell assays. Weinzierl, A., D. Features of TAP- independent MHC class I ligands revealed by quantitative mass spectrometry. Identification of HLA- A*0. HLA- A*0. 2- restricted CD8+ T- cell epitopes shared among group B enteroviruses. Yokoyama, Y., F. Matrilysin (MMP- 7) is a novel broadly expressed tumor antigen recognized by antigen- specific T cells. Adamopoulou. E., J. Human CD4+ T Cells Displaying Viral Epitopes Elicit a Functional Virus- Specific Memory CD8+ T Cell Response. Cancer immunoediting by GITR (glucocorticoid- induced TNF- related protein) ligand in humans: NK cell/tumor cell interactions. Identification and characterization of T- cell epitopes deduced from RGS5, a novel broadly expressed tumor antigen. Immunotherapy of renal cell carcinoma. Probst. J., B. Spontaneous cellular uptake of exogenous messenger RNA in vivo is nucleic acid- specific, saturable and ion dependent. Quantitative analysis of murine urine volatiles: in search of MHC- dependent differences. Identification of HLA- DR- bound peptides presented by human bronchoalveolar lavage cells in sarcoidosis. Weinzierl, A. O., C. Distorted relation between m. RNA copy number and corresponding major histocompatibility complex ligand density on the cell surface. Proteomics 6: 1. 02- 1. Asemissen, A.- M., U. Monocyte- dervied dendritic cells over- express CD8. Rheumatology 4. 5: 1. Dengjel, J., M.- D. Unexpected abundance of HLA class II presented peptides in primary renal cell carcinomas. Osterloh, P., K. Proteasomes shape the repertoire of T cells participating in antigen- specific immune responses. Characterization of the ribonuclease activity on the skin surface. Genetic Vaccines Ther. Rammensee, H.- G. Peptides made to order. Immunity 2. 5: 6. Rammensee, H.- G. Some considerations on the use of peptides and m. RNA for therapeutic vaccination against cancer. Rechtsteiner, G., T. Precursor frequency can compensate for lower TCR expression in T cell competition during priming in vivo. Comparative analysis of volatile constituents from mice and their urine. TLR2/TLR4- independent neutrophil activation and recruitment upon endocytosis of nucleosomes reveals a new pathway of innate immunity in systemic lupus erythematosus. Scheel, B., S. Therapeutic anti- tumor immunity triggered by injections of immunostimulating single- stranded RNA. Warger, T., N. Interaction of TLR2 and TLR4 ligands with the N- terminal domain of GP9. Carralot, J.- P., C. CD8+ T cells specific for a potential HLA- A*0. Chlamydophilapneumoniae are present in the PBMCs from infected patients. Carralot, J.- P., B. Production and characterization of amplified tumor- derived c. RNA libraries to be used as vaccines against metastatic melanomas. Nucleosome, the main autoantigen in systemic lupus erythematosus, induces direct dendritic cell activation via a My. D8. 8- independent pathway: consequences on inflammation. Dengjel, J., H.- G. Glycan side chains on naturally presented MHC class II ligands. Dengjel, J., O. Autophagy promotes MHC class II presentation of peptides form intracellular source proteins. USA 1. 02: 7. 92. Dittmann, J., K. CD8+ T- cell response against MUC- 1- derived peptides in gastrointestinal cancer survivors. Cancer Immunol., Immunother. Grosse- Hovest, L., W. Supraagonistic, bispecific single- chain antibody purified from the serum of cloned, transgenic cows induces T- cell- mediated killing of glioblastoma cells in vitro and in vivo. Cancer 1. 17: 1. 06. Herter, S., P. Dendritic cell aggresome- like- induced structure formation and delayed antigen presentation coincide in influenza virus- infected dendritic cells. Jung, G., Herrmann, T., Grosse- Hovest, L., Salih, H. R., Rammensee, H.- G.: Monoclonal and bispecific antibodies as novel therapeutics. In: Los, M., Gibson, S. B. Springer, Berlin, 2. Kramer, B. F., O. MAGED4- expression in renal cell carcinoma and identification of an HLA- A*2. MHC class I ligand from solid tumor tissue. Lessons to be learned from primary renal cell carcinomas: novel tumor antigens and HLA ligands for immunotherapy. Cancer Immunol., Immunother. Nastke, M.- D., L. Major contribution of codominant CD8 and CD4 T cell epitopes to the human cytomegalovirus- specific T cell repertoire. Neumeister, B., M. Legionella pneumophila down- regulates MHC class I expression of human monocytic host cells and thereby inhibits T cell activation. Pascolo, S., F. The non- classical HLA class I molecule HFE does not influence the NK- like activity contained in fresh human PBMCs and does not interact with NK cells. Immunol. 1. 7: 1. Ramirez, S. R., H. Glycoprotein 9. 6- actiated dendritic cells induce a CD8- biased T- cell response. Cell Stress Chaperones 1. Scheel, B., R. Toll- like receptor- dependent activation of several human blood cell types by protamine- condensed m. RNA. 3. 5: 1. 55. Schilbach, K., G. Cytotoxic minor histocompatibility antigen HA- 1- specific CD8+ effector memory T cells: Artificial APCs pave the way for clinical application by potent primary in vitro induction. Blood 1. 06: 1. 44- 1. Schuler, M. M., P. SNEP: SNP- derived epitope prediction program for minor H antigens. Immunogenetics 5. Tammiruusu, A., A. Clearance of Chlamydia pneumoniae infection in H- 2 class I- /- human leucocyte antigen- A2. Tenzer, S., B. Modeling the MHC class I pathway by combining predictions of proteasomal cleavage, TAP transport and MHC class I binding. Teufel, R., J.- P. Human peripheral blood mononuclear cells transfected with messenger RNA stimulate antigen- specific cytotoxic T lymphocytes in vitro. Walter, S., G. High frequencies of functionally impaired cytokeratin 1. CD8+ T cells in healthy HLA- A2+ donors. Wiemann, K., H. W. Systemic NKG2. D down- regulation impairs NK and CD8 T cell responses in vivo.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
December 2016
Categories |